[1]
Nielsen, T.B. et al. 2014. Inhomogeneous dose escalation increases expected local control for NSCLC patients with lymph node involvement without increased mean lung dose. Acta Oncologica. 53, 1 (Jan. 2014), 119–125. DOI:https://doi.org/10.3109/0284186X.2013.790560.